N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide

C31H38N10O6 — CID 146229922

IUPACN-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide
SMILESCC(NC(=O)[C@@H]1C[C@H](n2nncc2C(C)(C)O)CN1C(=O)/C(CC1CCCCC1)=N\C(=O)c1cnc2nccnc2c1)C(=O)C(N)=O
InChIInChI=1S/C31H38N10O6/c1-17(25(42)26(32)43)37-29(45)23-13-20(41-24(15-36-39-41)31(2,3)47)16-40(23)30(46)22(11-18-7-5-4-6-8-18)38-28(44)19-12-21-27(35-14-19)34-10-9-33-21/h9-10,12,14-15,17-18,20,23,47H,4-8,11,13,16H2,1-3H3,(H2,32,43)(H,37,45)/b38-22-/t17?,20-,23-/m0/s1
InChIKeyBJANEERCNFPIMD-DZMLDKPNSA-N
MW646.71 g/mol
LogP0.80
Rot. Bonds10

About N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide

N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide (PubChem CID 146229922) has the molecular formula C31H38N10O6 and a molecular weight of 646.71 g/mol. Its IUPAC name is N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide.

Molecular Properties

Compound NameN-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide
PubChem CID146229922
Molecular FormulaC31H38N10O6
Molecular Weight646.71 g/mol
Exact Mass646.30
IUPAC NameN-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide
SMILESCC(NC(=O)[C@@H]1C[C@H](n2nncc2C(C)(C)O)CN1C(=O)/C(CC1CCCCC1)=N\C(=O)c1cnc2nccnc2c1)C(=O)C(N)=O
InChIInChI=1S/C31H38N10O6/c1-17(25(42)26(32)43)37-29(45)23-13-20(41-24(15-36-39-41)31(2,3)47)16-40(23)30(46)22(11-18-7-5-4-6-8-18)38-28(44)19-12-21-27(35-14-19)34-10-9-33-21/h9-10,12,14-15,17-18,20,23,47H,4-8,11,13,16H2,1-3H3,(H2,32,43)(H,37,45)/b38-22-/t17?,20-,23-/m0/s1
InChIKeyBJANEERCNFPIMD-DZMLDKPNSA-N
XLogP0.80
TPSA228.61 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500646.71
LogP ≤ 50.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide?
The IUPAC name of N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide (CID 146229922) is N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide.
What is the SMILES notation for N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide?
The canonical SMILES for N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide is CC(NC(=O)[C@@H]1C[C@H](n2nncc2C(C)(C)O)CN1C(=O)/C(CC1CCCCC1)=N\C(=O)c1cnc2nccnc2c1)C(=O)C(N)=O.
What is the InChIKey of N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide?
The InChIKey is BJANEERCNFPIMD-DZMLDKPNSA-N. The full InChI is InChI=1S/C31H38N10O6/c1-17(25(42)26(32)43)37-29(45)23-13-20(41-24(15-36-39-41)31(2,3)47)16-40(23)30(46)22(11-18-7-5-4-6-8-18)38-28(44)19-12-21-27(35-14-19)34-10-9-33-21/h9-10,12,14-15,17-18,20,23,47H,4-8,11,13,16H2,1-3H3,(H2,32,43)(H,37,45)/b38-22-/t17?,20-,23-/m0/s1.
What are the key properties of N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide?
N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide has a molecular weight of 646.71 g/mol, XLogP of 0.80, 10 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[(2S,4S)-2-[(4-amino-3,4-dioxobutan-2-yl)carbamoyl]-4-[5-(2-hydroxypropan-2-yl)triazol-1-yl]pyrrolidin-1-yl]-3-cyclohexyl-1-oxopropan-2-ylidene]pyrido[2,3-b]pyrazine-7-carboxamide is sourced from PubChem (CID 146229922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).